Multimodal imaging approach to track theranostic nanoparticle accumulation in glioblastoma with magnetic resonance imaging and intravital microscopy
Authors:
- Giovanni Marco SaladinoGiovanni Marco Saladino
- Dilyana B. MangarovaDMDilyana B. Mangarova
- Kerem NernekliKNKerem Nernekli
- Jie WangJWJie Wang
- Giacomo AnnioGAGiacomo Annio
- Zahra Shokri VarniabZVZahra Shokri Varniab
- Zubeda KhatoonZKZubeda Khatoon
- Goreti Ribeiro MoraisGoreti Ribeiro Morais
- Yifeng ShiYSYifeng Shi
- Edwin ChangECEdwin Chang
- Laura J. PisaniLPLaura J. Pisani
- Grigory TikhomirovGTGrigory Tikhomirov
Open Access
- 19 March 2025
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (16) , 9986-9995
Abstract
Magnetic resonance imaging and two-photon intravital microscopy metrics were correlated to track Ferumoxytol-based theranostic nanoparticles targeting glioblastoma multiforme in vivo at both macroscopic and microscopic levels.Keywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD103638)
- Knut och Alice Wallenbergs Stiftelse (2023.0463)
- Stiftelsen Blanceflor Boncompagni Ludovisi, född Bildt (2024:1)
- National Science Foundation (ECCS-2026822)
- National Institutes of Health (S10RR026917-01)
This publication has 51 references indexed in Scilit:
- Tumor-Targeted Prodrug ICT2588 Demonstrates Therapeutic Activity against Solid Tumors and Reduced Potential for Cardiovascular ToxicityMolecular Pharmaceutics, 2014
- Safety and Effectiveness of Ferumoxytol in Hemodialysis Patients at 3 Dialysis Chains in the United States Over a 12-Month PeriodClinical Therapeutics, 2014
- Development of Novel Tumor‐Targeted Theranostic Nanoparticles Activated by Membrane‐Type Matrix Metalloproteinases for Combined Cancer Magnetic Resonance Imaging and TherapySmall, 2013
- MRI Assessment of Hepatic Iron Clearance Rates After USPIO Administration in Healthy AdultsInvestigative Radiology, 2012
- Target-Cancer-Cell-Specific Activatable Fluorescence Imaging Probes: Rational Design and in Vivo ApplicationsAccounts of Chemical Research, 2010
- Development of a Novel Tumor-Targeted Vascular Disrupting Agent Activated by Membrane-Type Matrix MetalloproteinasesCancer Research, 2010
- FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney diseaseAmerican Journal of Hematology, 2010
- Ferumoxytol for treatment of iron deficiency anemia in patients with chronic kidney diseaseExpert Opinion on Pharmacotherapy, 2009
- Ferumoxytol as an Intravenous Iron Replacement Therapy in Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2009
- Two-Photon Laser Scanning Fluorescence MicroscopyScience, 1990